Journey Strategic Wealth LLC Grows Position in Xylem Inc. $XYL

Journey Strategic Wealth LLC raised its stake in shares of Xylem Inc. (NYSE:XYL) by 10.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,030 shares of the industrial products company’s stock after acquiring an additional 487 shares during the period. Journey Strategic Wealth LLC’s holdings in Xylem were worth $651,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. Hanson & Doremus Investment Management lifted its position in shares of Xylem by 0.9% during the second quarter. Hanson & Doremus Investment Management now owns 8,516 shares of the industrial products company’s stock valued at $1,102,000 after purchasing an additional 77 shares in the last quarter. Princeton Global Asset Management LLC increased its stake in Xylem by 2.1% in the 2nd quarter. Princeton Global Asset Management LLC now owns 3,801 shares of the industrial products company’s stock valued at $492,000 after buying an additional 79 shares during the last quarter. Cidel Asset Management Inc. lifted its position in shares of Xylem by 6.1% during the 2nd quarter. Cidel Asset Management Inc. now owns 1,868 shares of the industrial products company’s stock worth $242,000 after buying an additional 108 shares in the last quarter. Harrington Investments INC boosted its stake in shares of Xylem by 0.5% in the 2nd quarter. Harrington Investments INC now owns 21,962 shares of the industrial products company’s stock worth $2,841,000 after buying an additional 120 shares during the last quarter. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in shares of Xylem by 3.7% in the first quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 3,389 shares of the industrial products company’s stock valued at $405,000 after acquiring an additional 121 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Insiders Place Their Bets

In related news, Director Victoria D. Harker sold 1,700 shares of the stock in a transaction dated Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total transaction of $251,838.00. Following the sale, the director owned 16,875 shares of the company’s stock, valued at approximately $2,499,862.50. This represents a 9.15% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm’s stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $139.96, for a total value of $139,960.00. Following the completion of the transaction, the chief accounting officer owned 2,957 shares of the company’s stock, valued at approximately $413,861.72. This represents a 25.27% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 13,121 shares of company stock worth $1,982,459 over the last 90 days. Corporate insiders own 0.27% of the company’s stock.

Wall Street Analysts Forecast Growth

XYL has been the topic of a number of recent analyst reports. UBS Group lifted their price target on Xylem from $168.00 to $175.00 and gave the stock a “buy” rating in a report on Thursday, November 6th. Zacks Research cut Xylem from a “strong-buy” rating to a “hold” rating in a research note on Tuesday. Cowen restated a “hold” rating on shares of Xylem in a research report on Tuesday, August 26th. Barclays raised their price objective on shares of Xylem from $165.00 to $172.00 and gave the stock an “overweight” rating in a report on Wednesday, October 29th. Finally, Stifel Nicolaus boosted their target price on shares of Xylem from $175.00 to $178.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Eight equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, Xylem presently has a consensus rating of “Moderate Buy” and a consensus price target of $166.90.

Xylem Trading Up 1.6%

Shares of Xylem stock opened at $140.21 on Friday. The stock has a market capitalization of $34.14 billion, a P/E ratio of 36.04, a P/E/G ratio of 2.50 and a beta of 1.15. Xylem Inc. has a 52-week low of $100.47 and a 52-week high of $154.27. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.43 and a current ratio of 1.96. The stock’s 50-day simple moving average is $146.16 and its 200 day simple moving average is $137.42.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.23 by $0.14. The company had revenue of $2.27 billion for the quarter, compared to analyst estimates of $2.22 billion. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The company’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.11 earnings per share. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. As a group, research analysts anticipate that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 23rd. Shareholders of record on Tuesday, November 25th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Tuesday, November 25th. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. Xylem’s payout ratio is presently 41.13%.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.